Evidence map›Paper›PMID 34705261›Full record

ReviewPhotochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology2021

Photodynamic disinfection and its role in controlling infectious diseases.

Rafael T Aroso, Fábio A Schaberle, Luís G Arnaut, Mariette M Pereira

Open access · hybridAbstract readReview
In one paragraph

Review in Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 75 citations in OpenAlex.

  1. Photodynamic anti-biofilm PHEMA/Rose Bengal hydrogels enhanced by iodide: evidence for hydrogen peroxide and triiodide formation.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Article
  2. Article
  3. Review
  4. Influence of porphyrin cationic charges on photoinactivation of Candida albicans morphotypes.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Article
  5. Article
  6. Enhancing Antibiotic Effect by Photodynamic: The Case ofAntibiotics (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Observational
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Rafael T ArosoChemistry Department, University of Coimbra, 3004-535, Coimbra, Portugal.
Fábio A SchaberleChemistry Department, University of Coimbra, 3004-535, Coimbra, Portugal.
Luís G ArnautChemistry Department, University of Coimbra, 3004-535, Coimbra, Portugal. lgarnaut@ci.uc.pt.ORCID http://orcid.org/0000-0002-3223-4819
Mariette M PereiraChemistry Department, University of Coimbra, 3004-535, Coimbra, Portugal. mmpereira@qui.uc.pt.
University of Coimbra · PT

Funding

fundação para a ciência e a tecnologia PD/BD/143123/2019fundação para a ciência e a tecnologia PTDC/QUI-OUT/27996/2017 (DUALPI)fundação para a ciência e a tecnologia UIDB/00313/2020
6 · The paper itself

Abstract

Photodynamic therapy is witnessing a revival of its origins as a response to the rise of multi-drug resistant infections and the shortage of new classes of antibiotics. Photodynamic disinfection (PDDI) of microorganisms is making progresses in preclinical models and in clinical cases, and the perception of its role in the clinical armamentarium for the management of infectious diseases is changing. We review the positioning of PDDI from the perspective of its ability to respond to clinical needs. Emphasis is placed on the pipeline of photosensitizers that proved effective to inactivate biofilms, showed efficacy in animal models of infectious diseases or reached clinical trials. Novel opportunities resulting from the COVID-19 pandemic are briefly discussed. The molecular features of promising photosensitizers are emphasized and contrasted with those of photosensitizers used in the treatment of solid tumors. The development of photosensitizers has been accompanied by the fabrication of a variety of affordable and customizable light sources. We critically discuss the combination between photosensitizer and light source properties that may leverage PDDI and expand its applications to wider markets. The success of PDDI in the management of infectious diseases will ultimately depend on the efficacy of photosensitizers, affordability of the light sources, simplicity of the procedures, and availability of fast and efficient treatments.

Indexed as

PhotochemotherapyAnimalsBacteriaBiofilmsCommunicable Disease ControlDrug Resistance, MicrobialDrug Resistance, MultipleFungiHumansMicrobial Sensitivity TestsNeoplasmsPhotosensitizing AgentsPhotosensitizing AgentsBacteriaBiofilmFungiInactivationPhotodynamic disinfectionVirus

Identifiers

PMID34705261
PMCPMC8548867
OpenAlexW3210863536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.